BR9700768A - Cepan tw928 de streptococcus equi cultura microbilóbica pura compreemdido uma bactéria vacina viva para combater infecção por streptococcus em cavalos processo par a preparação da mesma e uso da cepa tw928 de streptococcus equi - Google Patents
Cepan tw928 de streptococcus equi cultura microbilóbica pura compreemdido uma bactéria vacina viva para combater infecção por streptococcus em cavalos processo par a preparação da mesma e uso da cepa tw928 de streptococcus equiInfo
- Publication number
- BR9700768A BR9700768A BR9700768A BR9700768A BR9700768A BR 9700768 A BR9700768 A BR 9700768A BR 9700768 A BR9700768 A BR 9700768A BR 9700768 A BR9700768 A BR 9700768A BR 9700768 A BR9700768 A BR 9700768A
- Authority
- BR
- Brazil
- Prior art keywords
- streptococcus
- streptococcus equi
- strain
- horses
- microbilobic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96200171 | 1996-01-25 |
Publications (3)
Publication Number | Publication Date |
---|---|
BR9700768A true BR9700768A (pt) | 1998-11-03 |
BRPI9700768B1 BRPI9700768B1 (pt) | 2008-11-04 |
BRPI9700768B8 BRPI9700768B8 (pt) | 2016-11-16 |
Family
ID=8223610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9700768A BRPI9700768B8 (pt) | 1996-01-25 | 1997-01-24 | vacina viva para combater infecção por streptococcus em cavalos. |
Country Status (16)
Country | Link |
---|---|
US (1) | US5895654A (pt) |
EP (1) | EP0786518B1 (pt) |
JP (1) | JP3911058B2 (pt) |
AT (1) | ATE219511T1 (pt) |
AU (1) | AU703942B2 (pt) |
BR (1) | BRPI9700768B8 (pt) |
CA (1) | CA2195935C (pt) |
CZ (1) | CZ289530B6 (pt) |
DE (1) | DE69713408T2 (pt) |
DK (1) | DK0786518T3 (pt) |
ES (1) | ES2179261T3 (pt) |
NZ (1) | NZ314091A (pt) |
PL (1) | PL187163B1 (pt) |
PT (1) | PT786518E (pt) |
RU (1) | RU2194752C2 (pt) |
ZA (1) | ZA97452B (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2243730C (en) * | 1997-07-29 | 2009-12-22 | Akzo Nobel N.V. | Streptococcus equi vaccine |
US6682745B1 (en) | 1998-07-28 | 2004-01-27 | Christiaan Antonius Arnoldus Jacobs | Use of bacterium for manufacture of a vaccine |
TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US20080050367A1 (en) * | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
DE1033998T1 (de) * | 1997-12-03 | 2001-05-23 | Brigham And Women's Hospital, Boston | Methode zur unterdrückung von beta-amyloid-verwandten veränderungen in alzheimer |
FR2775601B1 (fr) * | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
ES2214217T3 (es) * | 1999-01-26 | 2004-09-16 | Akzo Nobel N.V. | Utilizacion de bacterias vivas atenuadas para la preparacion de una vacuna de administracion por la submucosa. |
US6541458B1 (en) | 1999-07-16 | 2003-04-01 | Merial | Feline calicivirus genes and vaccines in particular recombinant vaccines |
FR2796397B1 (fr) * | 1999-07-16 | 2006-09-01 | Merial Sas | Genes de calicivirus felin et vaccins notamment vaccins recombines |
US6420407B1 (en) | 1999-09-16 | 2002-07-16 | Gerald Horn | Ophthalmic formulation which modulates dilation |
US6730065B1 (en) | 2000-09-15 | 2004-05-04 | Ocularis Pharma, Inc. | Night vision composition |
US8889112B2 (en) * | 1999-09-16 | 2014-11-18 | Ocularis Pharma, Llc | Ophthalmic formulations including selective alpha 1 antagonists |
US20020082288A1 (en) * | 1999-09-16 | 2002-06-27 | Gerald Horn | Ophthalmic formulations comprising an imidazoline |
US20060211753A1 (en) * | 2000-11-03 | 2006-09-21 | Ocularis Pharma, Inc. | Method and composition which reduces stimulation of muscles which dilate the eye |
GB2370770B (en) * | 2001-01-03 | 2005-06-01 | Simon Connolly | Uses of Streptococcus Vaccines |
AR052051A1 (es) | 2004-12-15 | 2007-02-28 | Neuralab Ltd | Anticuerpos ab humanizados usados en mejorar la cognicion |
US8784810B2 (en) * | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
JP5889529B2 (ja) * | 2007-07-27 | 2016-03-22 | ヤンセン・サイエンシズ・アイルランド・ユーシー | アミロイド原性疾患の処置 |
JO3076B1 (ar) * | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
GB0801326D0 (en) | 2008-01-24 | 2008-03-05 | Animal Health Trust | Vaccines |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
GB201209014D0 (en) * | 2012-05-22 | 2012-07-04 | Moredun Res Inst | Vaccine |
CA2899339C (en) | 2013-02-01 | 2021-07-06 | Ocularis Pharma, Llc | Aqueous ophthalmic solutions of phentolamine and medical uses thereof |
US9089560B2 (en) | 2013-02-01 | 2015-07-28 | Ocularis Pharma, Llc | Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance |
EP3057613A1 (en) | 2013-10-17 | 2016-08-24 | Zoetis Services LLC | Methods and compositions for treatment of s. equi infection |
EP2949340A1 (en) * | 2014-05-30 | 2015-12-02 | IDT Biologika GmbH | Vaccine composition against Streptococcus suis infection |
GB2564481B (en) * | 2017-07-14 | 2019-10-23 | 4D Pharma Leon S L U | Process |
JP2022505950A (ja) | 2018-10-26 | 2022-01-14 | オキュフィア・ファーマ・インコーポレイテッド | 老眼、散瞳、および他の眼障害の治療のための方法および組成物 |
CN115368310A (zh) | 2021-05-18 | 2022-11-22 | 奥库菲尔医药公司 | 合成甲磺酸酚妥拉明的方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4110433A (en) * | 1976-04-23 | 1978-08-29 | Philips Roxane, Inc. | Equine rhinopneumonitis virus |
SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
US4582798A (en) * | 1984-11-23 | 1986-04-15 | Miles Laboratories, Inc. | Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine |
AR241545A1 (es) | 1985-07-12 | 1992-08-31 | Cornell Res Foundation Inc | Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos. |
US4788059A (en) * | 1985-07-15 | 1988-11-29 | Coopers Animal Health, Inc. | Equine strangles vaccine and the method of preparing and using the same |
IL86583A0 (en) * | 1987-06-04 | 1988-11-15 | Molecular Eng Ass | Vaccine containing a derivative of a microbe and method for the production thereof |
US5294441A (en) * | 1987-06-04 | 1994-03-15 | Washington University | Avirulent microbes and uses therefor: salmonella typhi |
US5468485A (en) * | 1987-06-04 | 1995-11-21 | Washington University | Avirulent microbes and uses therefor |
WO1989003427A1 (en) * | 1987-10-07 | 1989-04-20 | Washington University | A method of maintaining a desired recombinant gene in a genetic population of cells |
EP0626452B1 (en) * | 1993-05-17 | 1999-08-11 | Akzo Nobel N.V. | Vaccine against Streptococcus suis infection |
DE69417717T2 (de) * | 1993-12-20 | 1999-10-07 | Akzo Nobel N.V., Arnheim/Arnhem | Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen |
-
1997
- 1997-01-20 ZA ZA9700452A patent/ZA97452B/xx unknown
- 1997-01-21 NZ NZ314091A patent/NZ314091A/en not_active IP Right Cessation
- 1997-01-23 CZ CZ1997214A patent/CZ289530B6/cs not_active IP Right Cessation
- 1997-01-24 PL PL97318095A patent/PL187163B1/pl unknown
- 1997-01-24 DK DK97200194T patent/DK0786518T3/da active
- 1997-01-24 AT AT97200194T patent/ATE219511T1/de active
- 1997-01-24 PT PT97200194T patent/PT786518E/pt unknown
- 1997-01-24 ES ES97200194T patent/ES2179261T3/es not_active Expired - Lifetime
- 1997-01-24 JP JP01165297A patent/JP3911058B2/ja not_active Expired - Fee Related
- 1997-01-24 RU RU97101084/13A patent/RU2194752C2/ru active
- 1997-01-24 DE DE69713408T patent/DE69713408T2/de not_active Expired - Lifetime
- 1997-01-24 EP EP97200194A patent/EP0786518B1/en not_active Expired - Lifetime
- 1997-01-24 CA CA002195935A patent/CA2195935C/en not_active Expired - Lifetime
- 1997-01-24 BR BRPI9700768A patent/BRPI9700768B8/pt not_active IP Right Cessation
- 1997-01-27 US US08/789,727 patent/US5895654A/en not_active Expired - Lifetime
- 1997-01-28 AU AU12346/97A patent/AU703942B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA2195935C (en) | 2006-06-27 |
EP0786518A1 (en) | 1997-07-30 |
US5895654A (en) | 1999-04-20 |
ATE219511T1 (de) | 2002-07-15 |
PT786518E (pt) | 2002-10-31 |
ZA97452B (en) | 1997-08-15 |
DE69713408D1 (de) | 2002-07-25 |
BRPI9700768B1 (pt) | 2008-11-04 |
CZ289530B6 (cs) | 2002-02-13 |
BRPI9700768B8 (pt) | 2016-11-16 |
JP3911058B2 (ja) | 2007-05-09 |
AU703942B2 (en) | 1999-04-01 |
CA2195935A1 (en) | 1997-07-26 |
NZ314091A (en) | 1998-06-26 |
AU1234697A (en) | 1997-08-07 |
DE69713408T2 (de) | 2002-11-21 |
PL318095A1 (en) | 1997-08-04 |
DK0786518T3 (da) | 2002-09-16 |
EP0786518B1 (en) | 2002-06-19 |
ES2179261T3 (es) | 2003-01-16 |
CZ21497A3 (cs) | 1998-03-18 |
PL187163B1 (pl) | 2004-05-31 |
RU2194752C2 (ru) | 2002-12-20 |
JPH09215492A (ja) | 1997-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9700768A (pt) | Cepan tw928 de streptococcus equi cultura microbilóbica pura compreemdido uma bactéria vacina viva para combater infecção por streptococcus em cavalos processo par a preparação da mesma e uso da cepa tw928 de streptococcus equi | |
CY1105389T1 (el) | Hpv-e7 ως αγωγη εναντι του ιου θηλωματων ανθρωπου | |
LU91778I2 (fr) | Menveo - vaccin méningococcique des groupes A,C, W135 et Y conjugué. | |
PT1203817E (pt) | Compostos e metodos para imunoterapia e le diagnostic de tuberculose | |
DE60036698D1 (de) | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen | |
IL118603A (en) | Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof | |
CA2145397A1 (en) | Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines | |
GR3035135T3 (en) | Poultry vaccine containing infections bronchitis virus serotype 4/91. | |
NL300404I1 (en) | Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens | |
CA2022420A1 (en) | Escherichia coli vaccine | |
ES2137310T3 (es) | Vacuna contra una infeccion por streptococcus suis. | |
EP0804489A4 (pt) | ||
BR0316395A (pt) | Vacina atenuada viva contra pleuropneumonia porcina | |
CA2243730A1 (en) | Streptococcus equi vaccine | |
BRPI0508660A (pt) | composição de vacina eficaz na prevenção ou melhora da infecção por vìrus da doença bursal infecciosa; composição de vacina; isolado antigênico do vìrus da doença bursal infecciosa; e método para induzir proteção contra infecção do vìrus da doença bursal infecciosa | |
AR009650A1 (es) | Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna. | |
EP2364726A3 (en) | Vaccine against neisseria infection | |
NO20013101L (no) | Ytre overflateproteiner, deres gener og deres anvendelse | |
NZ512308A (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
RU96116250A (ru) | Штамм pestivirus, используемый для изготовления лапинизированной вирус вакцины против классической чумы свиней |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB34 | Technical and formal requirements: requirement - article 34 of industrial property law | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/11/2008, OBSERVADAS AS CONDICOES LEGAIS. |
|
B22O | Other matters related to patents and certificates of addition of invention: legal action concerning patent |
Free format text: INPI-52400.061557/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132378-91.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: RECKITT BENCKISER HEALTHCARE (UK) LIMITED, SANOFI-AVERTIS, SEPSICURE, L.L.C, THE AUSTRALIAN NATIONAL UNIVERSITY, THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY UNDIVIDED TRINITY OF QUEEN ELIZA |
|
B19A | Notification of judicial decision: notification of judicial decision |
Free format text: INPI-52400.129576/2014 SECAO JUDICIARIA DO RIO DE JANEIRO 13A VARA FEDERAL PROCESSO: NO0002752-82.2014.4.02.5101 AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL INPI E OUTRO REU: THE PROVOST FELLOWS AND SCHOLARS OF THE HOLY UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN E OUTRO DECISAO: ANTE A CERTEZA DO DIREITO E A PROVA INEQUIVOCA DOS AUTOS, CONCEDO A ANTECIPACAO DOS EFEITOS DA TUTELA, A FIM DE DETERMINAR A IMEDIATA READEQUACAO DO PRAZO DE VIGENCIA DA PATENTE PI 9700768-4 PARA VINTE ANOS CONTADOS A PARTIR DO RESPECTIVO DEPOSITO, NOS TERMOS DO PARAGRAFO UNICO DO ART.229 C/C O CAPUT DO ART. 40 DA LPI, OU SEJA, COM PRAZO DE VIGENCIA ATE 24/01/2017. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REFERENTE A RPI 1974 DE 04/11/2008, QUANTO AO PRAZO DE VALIDADE CONFORME DECISAO DA 13A VARA FEDERAL DO RIO DE JANEIRO, PROCESSO: 0002752-82.2014.4.02.5101 (2014.51.01.002752-7 - INPI 52400.129576/2014-52 |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 24.01.2017 |